Half-year report · Q2
4978.TEDINET S100UOVO
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | −¥149m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥242m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | −¥103m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥40m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥70m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥103m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥62m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥104m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥31m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥61m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥104m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥61m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥9.4bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥9.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥679m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥741m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.7bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥8.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥131m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥11m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥58m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥412m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥404m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥46m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥681m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥544m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-1.14 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.37 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.71 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 92.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment ordinary income | 2024-04-01 → 2024-09-30 | −¥378m |
| jpcrp040300-q2r_E27585-000Medical Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥176m |
| jpcrp040300-q2r_E27585-000Medical Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥176m |
| jpcrp040300-q2r_E27585-000Medical Businessreportable segment | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥8m |
| jpcrp040300-q2r_E27585-000Research Support Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E27585-000Research Support Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E27585-000Research Support Businessreportable segment | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥267m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| —segment total | segment ordinary income | 2024-04-01 → 2024-09-30 | ¥275m |
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2023-09-30 | −¥214m |
| jpcrp040300-q2r_E27585-000Medical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E27585-000Medical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E27585-000Medical Businessreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥110m |
| jpcrp040300-q2r_E27585-000Research Support Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E27585-000Research Support Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.0bn |
| jpcrp040300-q2r_E27585-000Research Support Businessreportable segment | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥174m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | segment ordinary income | 2023-04-01 → 2023-09-30 | ¥284m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 483
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in operating activities | Prior1YTDDuration | 58231000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -131156000 | JPY |
| Purchase of short term investment securities inv cf | Prior1YTDDuration | -1500000000 | JPY |
| Purchase of short term investment securities inv cf | CurrentYTDDuration | － | JPY |
| Proceeds from redemption of securities inv cf | Prior1YTDDuration | 3000000000 | JPY |
| Proceeds from redemption of securities inv cf | CurrentYTDDuration | 1600000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -1509193000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -2000450000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | Prior1YTDDuration | 103790000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | CurrentYTDDuration | － | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -31740000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -11995000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -15283000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -279000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 682000 | JPY |
| Other net inv cf | Prior1YTDDuration | -1352000 | JPY |
| Other net inv cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 46220000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -412042000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 680711000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | － | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 680711000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 66358000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -30320000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 170810000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 107191000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1914569000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 2939057000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 2085379000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 3046249000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 215824000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 254603000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 4576000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 4971000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 834000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 190000 | JPY |
| Compensations sga | Prior1YTDDuration | 76415000 | JPY |
| Compensations sga | CurrentYTDDuration | 63518000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E27585-000ResearchSupportBusinessReportableSegmentsMember | 1025305000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E27585-000MedicalBusinessReportableSegmentsMember | 121834000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 1147139000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 1147139000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E27585-000ResearchSupportBusinessReportableSegmentsMember | 1025305000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E27585-000MedicalBusinessReportableSegmentsMember | 121834000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 1147139000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 1147139000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |